Rite Aid Statement on CDC Recommendation Regarding COVID-19 Vaccine “Boosters”
September 24 2021 - 1:59PM
Business Wire
Today the Centers for Disease Control and Prevention (CDC)
concurred with previous recommendations made by the Food and Drug
Administration (FDA) and the Advisory Committee on Immunization
Practices (ACIP), officially recommending “booster” doses of the
Pfizer-BioNTech COVID-19 vaccine for certain eligible populations
at least 6 months after the second dose of the Pfizer-BioNTech
COVID-19 vaccine.
As a proud partner in the Federal Retail Pharmacy Program, Rite
Aid is prepared to begin administering third-dose “boosters” of the
Pfizer vaccine starting immediately, in line with the CDC’s
guidance. Customers may receive their booster dose at Rite Aid
regardless of where they received their primary series.
Rite Aid has been on the front lines of the pandemic since the
beginning, offering COVID-19 testing and administering vaccinations
to keep our communities healthy and thriving. Pharmacists are
prepared to administer third doses in an effort to further protect
the most vulnerable populations.
At this time, additional doses are recommended only for:
- People 65 years and older and residents in long-term care
settings
- People aged 18-64 years with underlying medical conditions
- People aged 18-64 years who are at increased risk for COVID-19
exposure and transmission because of occupational or institutional
setting
Currently, boosters are only recommended for those who received
the Pfizer vaccine for their primary series. The CDC is continuing
to evaluate available data in the coming weeks to make
recommendations for those who initially received the Moderna and
Johnson & Johnson vaccines.
Eligible customers may walk in immediately, or schedule an
appointment at https://www.riteaid.com/pharmacy/scheduler beginning
Saturday, September 25, to receive a third dose of the Pfizer
vaccine. Flu and other vaccines are also available in-store and can
be scheduled via the online scheduling tool.
Rite Aid encourages those who still have not received their
primary series to do so. Please visit our website,
www.riteaid.com/covid-19, for timely, accurate information on
COVID-19 vaccines and testing in each community we serve.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210924005489/en/
MEDIA: Brad Ducey 717-975-5718 Bradley.Ducey@riteaid.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2023 to Apr 2024